Anti-Androgen Treatment for COVID-19

NCT04446429 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

268

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV2
Androgenetic Alopecia
Prostate Cancer
Benign Prostatic Hyperplasia
SARS (Severe Acute Respiratory Syndrome)

Interventions

DRUG: Proxalutamide
OTHER: Standard of Care

Sponsor

Applied Biology, Inc.